CompletedNCT04476225
Induced Pluripotent Stem Cells for Disease Research
Studying Hirschsprung disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Steve Finkbeiner, MD, PhDUniversity of California, San Francisco
- Enrollment
- 1 enrolled
- Eligibility
- 13-100 years · All sexes
- Timeline
- 2022 – 2022
Study locations (1)
- University of California, San Francisco, San Francisco, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04476225 on ClinicalTrials.govOther trials for Hirschsprung disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06590142Hirschsprung's Advances; Working Towards Autologous tIssue therapIesAlder Hey Children's NHS Foundation Trust
- RECRUITINGNANCT06650683Impact of Providing Nursing Support on Parental Stress Related to Preoperative Care of a Newborn with Hirschsprung's DiseaseAssistance Publique Hopitaux De Marseille
- RECRUITINGNCT04622410Registry for Hirschsprung Disease of the BELAPSUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGNCT00478712Hirschsprung Disease Genetic StudyNYU Langone Health